tci Part B Insider - 2005 Issue 24

CHEMOTHERAPY PAYMENTS: Drug Payments For These Commonly Prescribed Drugs Drop Up To 38 Percent In July

Overall drug payments face 2 percent cutIf oncologists were hoping for a break from third-quarter 2005 drug payments, they were sadly mistaken.Even though the Centers for Medicare and Medicaid Services has been collecting information from physicians who say they can't obtain drugs at the rock-bottom prices Medicare has been paying, the newest numbers don't show much improvement. CMS released the latest drug rates, based on 106 percent of Average Sales Price data, and many chemotherapy drugs were treated to sharp decreases.The hardest hit include Cytarabine (J9100 and J9110), which dropped around 38 percent; Etoposide (J9181 and J9182)...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.